YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Celgene to acquire Juno for $9B

Posted online

Celgene Corp. penned a deal to acquire Juno Therapeutics Inc. for about $9 billion.

Celgene would gain Juno's class of therapies known as CAR-T, which use the body's own immune system to battle cancer.

The acquisition is reportedly one of Celgene's largest deals ever.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences